| Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines … RA Sperling, PS Aisen, LA Beckett, DA Bennett, S Craft, AM Fagan, ... Alzheimer's & dementia 7 (3), 280-292, 2011 | 5633 | 2011 |
| NIA‐AA research framework: toward a biological definition of Alzheimer's disease CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, B Dunn, SB Haeberlein, ... Alzheimer's & Dementia 14 (4), 535-562, 2018 | 2505 | 2018 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 2321 | 2014 |
| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 1430 | 2013 |
| Imaging β-amyloid burden in aging and dementia CC Rowe, S Ng, U Ackermann, SJ Gong, K Pike, G Savage, TF Cowie, ... Neurology 68 (20), 1718-1725, 2007 | 1133 | 2007 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 929 | 2010 |
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 901 | 2015 |
| β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease KE Pike, G Savage, VL Villemagne, S Ng, SA Moss, P Maruff, CA Mathis, ... Brain 130 (11), 2837-2844, 2007 | 838 | 2007 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 823 | 2016 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 775 | 2011 |
| Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ... The Lancet Neurology 7 (2), 129-135, 2008 | 659 | 2008 |
| High performance plasma amyloid-β biomarkers for Alzheimer’s disease A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ... Nature 554 (7691), 249-254, 2018 | 636 | 2018 |
| Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association KA Johnson, S Minoshima, NI Bohnen, KJ Donohoe, NL Foster, ... Journal of Nuclear Medicine 54 (3), 476-490, 2013 | 568 | 2013 |
| The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of … K Ellis, A Bush, D Darby, D De Fazio, J Foster, P Hudson, ... Cambridge University Press, 2009 | 562 | 2009 |
| Tau imaging: early progress and future directions VL Villemagne, MT Fodero-Tavoletti, CL Masters, CC Rowe The Lancet Neurology 14 (1), 114-124, 2015 | 435 | 2015 |
| Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C] PIB positron emission tomography P Edison, CC Rowe, JO Rinne, S Ng, I Ahmed, N Kemppainen, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (12), 1331-1338, 2008 | 414 | 2008 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 395 | 2015 |
| Relationship between atrophy and β‐amyloid deposition in Alzheimer disease G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ... Annals of neurology 67 (3), 317-324, 2010 | 369 | 2010 |
| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 350 | 2012 |
| 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease MT Fodero-Tavoletti, N Okamura, S Furumoto, RS Mulligan, AR Connor, ... Brain 134 (4), 1089-1100, 2011 | 334 | 2011 |
